tamibarotene has been researched along with Sclerosis, Systemic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akamata, K; Asano, Y; Ichimura, Y; Kadono, T; Noda, S; Sato, S; Shudo, K; Takahashi, T; Taniguchi, T; Toyama, T | 1 |
1 other study(ies) available for tamibarotene and Sclerosis, Systemic
Article | Year |
---|---|
Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.
Topics: Animals; Benzoates; Bleomycin; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Endothelial Cells; Female; Fibroblasts; Fibrosis; Flow Cytometry; Humans; Immunohistochemistry; Interleukins; Macrophages; Mast Cells; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phenotype; Protein Serine-Threonine Kinases; Random Allocation; Real-Time Polymerase Chain Reaction; Scleroderma, Systemic; Sensitivity and Specificity; Tetrahydronaphthalenes; Tumor Necrosis Factor-alpha | 2016 |